Esanik Therapeutics, Inc. — Form D
Esanik Therapeutics, Inc. of Northville, MI, a company, filed a Form D exempt-offering notice with the SEC on 2024-11-14. The offering totals $3.3M, of which $3.3M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2024-11-14
- Form: D
- Accession: 0002044524-24-000001
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $3.3M
- Amount sold: $3.3M
- Investors: 4
- Date of first sale: 2024-10-31
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-529423
Issuer
- Name: Esanik Therapeutics, Inc.
- CIK: 0002044524
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 120 West Main Street Suite 300, Northville, MI, 48167
- Phone: 610-725-1500
Officers, directors & promoters (2)
| Name | Role | Location |
|---|
| John Mel Sorensen | Executive Officer | Northville, MI |
| John Mel Sorensen | Related Person | Northville, MI |
Other filings by this issuer (1)
More